SCHEMBL5705356

SCHEMBL5705356

CC(CCC=O)(CCCCCCCCCCCC(C)(CCC(O)O)c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
RIPK1 Q13546 2/20 0.37
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
KIF11 P52732 6/20 0.32
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
ACACB O00763 1/20 0.31
ACACA Q13085 1/20 0.31
BCHE P06276 1/20 0.31
BACE1 P56817 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
CTSK P43235 1/20 0.30
PTGER4 P35408 1/20 0.30
PTGER3 P43115 1/20 0.30
KMT2A Q03164 2/20 0.30
MAPT P10636 1/20 0.30
MEN1 O00255 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705434 1.00 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL5705247 1.00 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL5705353 0.79 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL7027201 0.77 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL7021873 0.77 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL7027006 0.77 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL5705246 0.77 CYP2C19 (0.40) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL5705432 0.75 CYP2C19 (0.41) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL19678172 0.75 ACACB (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL19678201 0.75 ACACB (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP claimed
WO-2002030860-A9 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS INC (US) 2003-02-20 WO claimed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO claimed
EP-1701931-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics, Inc. (US) 2006-09-20 EP disclosed
WO-2005068412-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 WO disclosed
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP disclosed
WO-2002030860-A9 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS INC (US) 2003-02-20 WO disclosed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO disclosed